Skip to main content

Outcomes of Upfront Docetaxel with Hormone Therapy in elderly patients with metastatic hormone-naïve prostate cancer.

Challapalli
Amarnath
Department of Oncology
Bristol Cancer Institute
Bristol
United Kingdom
Show all authors
Kirk
Hannah
Department of Oncology
Bristol Cancer Institute
Bristol
United Kingdom
White
Paul
Department of Statistics
University of West of England
Bristol
United Kingdom
Bahl
Amit
Department of Onclogy
Bristol Cancer Institute
Bristol
United Kingdom

Tabs

Speciality: 
Oncology (medical)
Keywords: 
Hormone naive, Docetaxel, metastatic prostate cancer